Liminatus Pharma, Inc.
LIMN
$9.02
$0.212.38%
NASDAQ
| 03/31/2025 | 12/31/2024 | 03/31/2024 | |||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -- | -87.10% | -99.48% | ||
| Total Receivables | -- | 288.25% | -- | ||
| Inventory | -- | -- | -- | ||
| Prepaid Expenses | -- | 609.09% | -- | ||
| Finance Division Loans and Leases Current | -- | -- | -- | ||
| Total Finance Division Other Current Assets | -- | -- | -- | ||
| Other Current Assets | -- | 66.79% | -- | ||
| Total Current Assets | -- | 135.70% | -- | ||
|
|
|||||
| Total Current Assets | -- | 135.70% | -- | ||
| Net Property, Plant & Equipment | -- | 0.00% | -- | ||
| Long-term Investments | -- | -- | -- | ||
| Goodwill | -- | -- | -- | ||
| Total Other Intangibles | -- | -- | -- | ||
| Finance Div Loans & Leases LT | -- | -- | -- | ||
| Total Finance Div Other LT Assets | -- | -- | -- | ||
| Total Other Assets | -- | -- | -- | ||
| Total Assets | -- | 141.26% | -- | ||
|
|
|||||
| Total Accounts Payable | -- | 59.06% | -- | ||
| Total Accrued Expenses | -99.94% | 260.96% | -- | ||
| Short-term Debt | -- | 24.44% | -- | ||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | ||
| Finance Division Debt Current | -- | -- | -- | ||
| Total Finance Division Other Current Liabilities | -- | 0.00% | -- | ||
| Total Other Current Liabilities | -- | 0.00% | -- | ||
| Total Current Liabilities | -99.99% | 37.22% | -- | ||
|
|
|||||
| Total Current Liabilities | -99.99% | 37.22% | -- | ||
| Long-Term Debt | -- | -- | -- | ||
| Short-term Debt | -- | 24.44% | -- | ||
| Capital Leases | -- | -- | -- | ||
| Finance Division Debt Non Current | -- | -- | -- | ||
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | ||
| Total Other Liabilities | -- | -- | -- | ||
| Total Liabilities | -99.99% | 37.22% | -- | ||
|
|
|||||
| Common Stock & APIC | -100.00% | 0.00% | -- | ||
| Retained Earnings | 100.00% | -14.12% | -- | ||
| Treasury Stock & Other | -- | -- | -- | ||
| Total Common Equity | 99.99% | -22.45% | -62.33% | ||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | ||
| Preferred Stock Non Redeemable | -- | -- | -- | ||
| Preferred Stock Convertible | -- | -- | -- | ||
| Preferred Stock, Others | -- | -- | -- | ||
| Total Preferred Equity | -- | -- | -- | ||
|
|
|||||
| Total Common Equity | 99.99% | -22.45% | -62.33% | ||
| Total Preferred Equity | -- | -- | -- | ||
| Total Minority Interest | -- | -- | -- | ||
| Total Equity | 99.99% | -22.45% | -62.33% | ||
|
|
|||||